{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:37:51Z","timestamp":1794371871485,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":56,"publisher":"Humana Press","isbn-type":[{"value":"9781607615842","type":"print"},{"value":"9781607615859","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-60761-585-9_18","type":"book-chapter","created":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T11:31:37Z","timestamp":1264159897000},"page":"261-285","source":"Crossref","is-referenced-by-count":7,"title":["Determining the Activity of Mucosal Adjuvants"],"prefix":"10.1007","author":[{"given":"Barbara C.","family":"Baudner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Del","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1358\/dof.2004.029.07.854169","volume":"29","author":"B. C. Baudner","year":"2004","unstructured":"Baudner, B. C., Verhoef, J. C., Junginger, H. E., Del Giudice, G. (2004) Mucosal adjuvants and delivery systems for oral and nasal vaccination. Drugs Future 29, 721\u2013732.","journal-title":"Drugs Future"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0169-409X(01)00169-7","volume":"51","author":"E. A. McNeela","year":"2001","unstructured":"McNeela, E. A., Mills, K. H. (2001) Manipulating the immune system: humoral versus cell-mediated immunity. Adv Drug Deliv Rev 51, 43\u201354.","journal-title":"Adv Drug Deliv Rev"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1600-065X.1999.tb01339.x","volume":"170","author":"C. Czerkinsky","year":"1999","unstructured":"Czerkinsky, C., Anjuere, F., McGhee, J. R., George-Chandy, A., Holmgren, J., Kieny, M. P., Fujiyashi, K., Mestecky, J. F., Pierrefite-Carle, V., Rask, C., Sun, J. B. (1999) Mucosal immunity and tolerance: relevance to vaccine development. Immunol Rev 170, 197\u2013222.","journal-title":"Immunol Rev"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1084\/jem.142.6.1550","volume":"142","author":"N. S. Pierce","year":"1975","unstructured":"Pierce, N. S., Gowans, J. L. (1975) Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med 142, 1550\u20131563.","journal-title":"J Exp Med"},{"key":"18_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1128\/IAI.29.1.91-97.1980","volume":"29","author":"J. D. Clements","year":"1980","unstructured":"Clements, J. D., Yancy, R. J., Finkelstein, R. A. (1980) Properties of homogeneous heat-labile enterotoxin from Escherichia coli. Infect Immun 29, 91\u201397.","journal-title":"Infect Immun"},{"key":"18_CR6","first-page":"301","volume":"59","author":"N. Lycke","year":"1986","unstructured":"Lycke, N., Holmgren, J. (1986) Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301\u2013308.","journal-title":"Immunology"},{"key":"18_CR7","first-page":"1","volume-title":"Sourcebook of Bacterial Protein Toxins","author":"R. Rappuoli","year":"1991","unstructured":"Rappuoli, R., Pizza, M. (1991) Structure and evolutionary aspects of ADP-ribosylating toxins, in (Alouf, J., Freer, J., eds.) Sourcebook of Bacterial Protein Toxins. Academic, New York, pp 1\u201320."},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0167-5699(99)01523-6","volume":"20","author":"R. Rappuoli","year":"1999","unstructured":"Rappuoli, R., Pizza, M., Douce, G., Dougan, G. (1999) A relationship between the structure and function of cholera and Escherichia coli heat labile enterotoxins and their immunological activity at mucosal surfaces. Immunol Today 20, 493\u2013500.","journal-title":"Immunol Today"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/IAI.64.12.5434-5438.1996","volume":"64","author":"C. Magagnoli","year":"1996","unstructured":"Magagnoli, C., Manetti, R., Fontana, M. R., Giannelli, V., Giuliani, M. M., Rappuoli, R., Pizza, M. (1996) Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat labile enterotoxin. Infect Immun 64, 5434\u20135438.","journal-title":"Infect Immun"},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/IAI.8.2.208-214.1973","volume":"8","author":"J. Holmgren","year":"1973","unstructured":"Holmgren, J., Lonnroth, I., Svennerholm, L. (1973) Tissue receptor for cholera exotoxin: postulated structure from studies with GM1-ganglioside and related glycolipids. Infect Immun 8, 208\u2013214.","journal-title":"Infect Immun"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1139\/m89-109","volume":"35","author":"S. T. Sugii","year":"1989","unstructured":"Sugii, S. T. (1989) Binding specificities of heat-labile enterotoxins isolated from porcine and human enterotoxigenic Escherichia coli heat-labile toxin and cholera toxin. Can J Microbiol 35, 670\u2013673.","journal-title":"Can J Microbiol"},{"key":"18_CR12","first-page":"133","volume":"87","author":"M. Pizza","year":"2003","unstructured":"Pizza, M., Fontana, M. R., Scarlato, V., Rappuoli, R. (2003) Genetic detoxification of bacterial toxins page range. Methods Mol Med 87, 133\u2013151.","journal-title":"Methods Mol Med"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1084\/jem.187.7.1123","volume":"187","author":"M. M. Giuliani","year":"1998","unstructured":"Giuliani, M. M., Del Giudice, G., Gianelli, V., Dougan, G., Douce, D., Rappuoli, R., Pizza, M. (1998) Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J Exp Med 187, 1123\u20131132.","journal-title":"J Exp Med"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1046\/j.1365-2567.1996.d01-790.x","volume":"89","author":"C. D. Partidos","year":"1996","unstructured":"Partidos, C. D., Pizza, M., Rappuoli, R., Steward, M. W. (1996) The adjuvant effect of a non-toxic mutant heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide. Immunology 89, 483\u2013487.","journal-title":"Immunology"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/(SICI)1521-4141(199804)28:04<1243::AID-IMMU1243>3.0.CO;2-E","volume":"28","author":"L. deHaan","year":"1998","unstructured":"deHaan, L., Feil, I. K., Verweij, W. R., Holtrop M., Hol W. G., Agsteribbe, E., Wilschut, J.. (1998) Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin. Eur J Immunol 28, 1243\u20131250.","journal-title":"Eur J Immunol"},{"key":"18_CR16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/IAI.63.5.1617-1623.1995","volume":"63","author":"B. L. Dickinson","year":"1995","unstructured":"Dickinson, B. L., Clements, J. D. (1995) Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63, 1617\u20131623.","journal-title":"Infect Immun"},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/IAI.67.12.6270-6280.1999","volume":"67","author":"E. J. Ryan","year":"1999","unstructured":"Ryan, E. J., McNeela, E., Murphy, G. A., Stewart, H., O\u2019Hagan, D., Pizza, M., Rappuoli, R., Mills, K. H. (1999) Mutants of Escherichia coli heat labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the non-toxic AB complex and enzyme activity on Th1 and Th2 cells. Infect Immun 67, 6270\u20136280.","journal-title":"Infect Immun"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0264-410X(97)00153-9","volume":"16","author":"M. Marchetti","year":"1998","unstructured":"Marchetti, M., Rossi, M., Giannelli, V., Giuliani, M. M., Pizza, M., Censini, S., Covacci, A., Massari, P., Pagliaccia, C., Manetti, R., Telford, J. L., Douce, G., Dougan, G., Rappuoli, R., Ghiara, P. (1998) Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 16, 33\u201337.","journal-title":"Vaccine"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1128\/IAI.70.3.1443-1452.2002","volume":"70","author":"H. Jakobsen","year":"2002","unstructured":"Jakobsen, H., Bjarnarson, S., Del Giudice, G., Moreau, M., Siegrist, C. A., Jonsdottir, I. (2002) Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice. Infect Immun 70, 1443\u20131452.","journal-title":"Infect Immun"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1073\/pnas.92.5.1644","volume":"92","author":"G. Douce","year":"1995","unstructured":"Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenghini, M., Rappuoli, R., Dougan, G. (1995) Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci USA 92, 1644\u20131648.","journal-title":"Proc Natl Acad Sci USA"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/423327","volume":"190","author":"F. Mawas","year":"2004","unstructured":"Mawas, F., Peyre, M., Beignon, A. S., Frost, L., Del Giudice, G., Rappuoli, R., Muller, S., Sesardic, D., Partidos, C. D. (2004) Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria following transcutaneous immunization with glyconjugate polyribosyl ribitol phosphate\u2013cross-reacting material197 vaccine. J Infect Dis 190, 1177\u20131182.","journal-title":"J Infect Dis"},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev.immunol.19.1.523","volume":"19","author":"G. Del Giudice","year":"2001","unstructured":"Del Giudice, G., Covacci, A., Telford, J. L., Montecucco, C., Rappuoli, R. (2001) The design of vaccines against Helicobacter pylori and their development. Ann Rev Immunol 19, 523\u2013563.","journal-title":"Ann Rev Immunol"},{"key":"18_CR23","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","volume":"177","author":"J. Dietrich","year":"2006","unstructured":"Dietrich, J., Andersen, C., Rappuoli, R., Doherty, T. M., Jensen, C. G., Andersen, P. (2006) Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 177, 6353\u20136360.","journal-title":"J Immunol"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1086\/381708","volume":"189","author":"B. Baudner","year":"2004","unstructured":"Baudner, B., Moranti, M., Giuliani, M. M., Verhoef, J. C., Junginger, H. E., Costantino, P., Rappuoli, R., Del Giudice, G. (2004) Modulation of immune response to group C meningococcal coniugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chirosan delivery system. J Infect Dis 189, 828\u2013832.","journal-title":"J Infect Dis"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/eji.200425850","volume":"35","author":"S. P. Bjarnarson","year":"2005","unstructured":"Bjarnarson, S. P., Jakobsen, H., Del Giudice, G., Trannoy, E., Siegrist, C. A., Jonsdottir, I. (2005) The advantage of mucosal immunization for polysaccharide-specific memory responses in early life. Eur J Immunol 35, 1037\u20131045.","journal-title":"Eur J Immunol"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0165-2478(99)00013-9","volume":"67","author":"C. D. Partidos","year":"1999","unstructured":"Partidos, C. D., Salani, B. F., Pizza, M., Rappuoli, R. (1999) Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides. Immunol Lett 67, 209\u2013216.","journal-title":"Immunol Lett"},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1046\/j.1365-2567.2000.00090.x","volume":"101","author":"J. A. Neidleman","year":"2000","unstructured":"Neidleman, J. A., Vajdy, M., Ugozzoli, M., Ott, G., O\u2019Hagan, D. (2000) Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55. Immunology 101, 154\u2013160.","journal-title":"Immunology"},{"key":"18_CR28","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.4049\/jimmunol.163.12.6502","volume":"163","author":"C. P. Simmons","year":"1999","unstructured":"Simmons, C. P., Mastroeni, P., Fowler, R., Ghaem-maghami, M., Lycke, N., Pizza, M., Rappuoli, R., Dougan, G. (1999) MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants. J Immunol 163, 6502\u20136510.","journal-title":"J Immunol"},{"key":"18_CR29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4049\/jimmunol.166.2.1106","volume":"166","author":"C. P. Simmons","year":"2001","unstructured":"Simmons, C. P., Hussell, T., Sparer, T., Walzl, G., Openshaw, P., Dougan, G. (2001) Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses. J Immunol 166, 1106\u20131113.","journal-title":"J Immunol"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1365-2567.1998.00441.x","volume":"93","author":"M. Ugozzoli","year":"1998","unstructured":"Ugozzoli, M., O\u2019Hagan, D. T., Ott, G. S. (1998) Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses. Immunology 93, 563\u2013571.","journal-title":"Immunology"},{"key":"18_CR31","doi-asserted-by":"publisher","first-page":"7927","DOI":"10.1016\/j.vaccine.2007.09.004","volume":"25","author":"M. Tempesta","year":"2007","unstructured":"Tempesta, M., Camero, M., Bellacicco, A. L., Tarsitano, E., Lo russo, A., Martella, V., Decaro, N., Del Giudice, G., Cassone, A., Quaranta, A., Buonavoglia, C. (2007) Caprine herpesvirus 1 vaccine with the LTK63 mutant as a mucosal adjuvant induces strong protection against genital infection in goats. Vaccine 25, 7927\u20137930.","journal-title":"Vaccine"},{"key":"18_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0168-3659(00)00330-8","volume":"70","author":"M. Singh","year":"2001","unstructured":"Singh, M., Briones, M., O\u2019Hagan, D. T. (2001) A novel bioadhesive intranasal delivery system for inactivated influenza vaccines. J Control Release 70, 267\u2013276.","journal-title":"J Control Release"},{"key":"18_CR33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/CDLI.8.3.652-657.2001","volume":"8","author":"J. D. Barackman","year":"2001","unstructured":"Barackman, J. D., Ott, G., Pine, S., O\u2018Hagan, D. T. (2001) Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization. Clin Diagn Lab Immunol 8, 652\u2013657.","journal-title":"Clin Diagn Lab Immunol"},{"key":"18_CR34","doi-asserted-by":"crossref","unstructured":"Bonenfant, C., Dimier-Poisson, I., Velge-Roussel, F., Buzoni-Gatel, D., Del Giudice, G., Rappuoli, R., Bout, D. (Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun 69, 1605\u20131612","DOI":"10.1128\/IAI.69.3.1605-1612.2001"},{"key":"18_CR35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.vaccine.2008.12.010","volume":"27","author":"J. F. Romero","year":"2009","unstructured":"Romero, J. F., Ciabattini, A., Guillaume, P., Frank, G., Ruggiero, P., Pettini, E., Del Giudice, G., Medaglioni, D., Corradin, G. (2009) Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge. Vaccine 27, 1266\u20131271.","journal-title":"Vaccine"},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1016\/j.vaccine.2007.01.036","volume":"25","author":"M. Kende","year":"2007","unstructured":"Kende, M., Tan, X., Wlazlowski, C., Williams, R., Lindsey, C., Del Giudice, G. (2007) Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72. Vaccine 25, 3219\u20133227.","journal-title":"Vaccine"},{"key":"18_CR37","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1128\/JVI.80.10.4962-4970.2006","volume":"80","author":"I. Stephenson","year":"2006","unstructured":"Stephenson, I., Zambon, M. C., Rudin, A., Colegate, A., Podda, A., Bugarini, R., Del Giudice, G., Minutello, A., Bonnington, S., Holmgren, J., Mills, K. H., Nicholson, K. G. (2006) Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. J Virol 80, 4962\u20134970.","journal-title":"J Virol"},{"key":"18_CR38","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1093\/nar\/10.20.6487","volume":"10","author":"M. J. Zoller","year":"1982","unstructured":"Zoller, M. J., Smith, M. (1982) Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucl Acid Res 10, 6487\u20136500.","journal-title":"Nucl Acid Res"},{"key":"18_CR39","volume-title":"Molecular Cloning: A Laboratory Manual","author":"J. Sambrook","year":"1989","unstructured":"Sambrook, J., Fritsch, E. F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual.. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY."},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1006\/meth.1999.0840","volume":"19","author":"G. Del Giudice","year":"1999","unstructured":"Del Giudice, G., Pizza, M., Rappuoli, R. (1999) Mucosal delivery of vaccines. Methods 19, 148\u2013155.","journal-title":"Methods"},{"key":"18_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1126\/science.183.4122.334","volume":"183","author":"S. T. Donta","year":"1973","unstructured":"Donta, S. T., Moon, H. W., Whipp, S. C. (1973) Detection and use of heat-labile Escherichia coli enterotoxin with the use of adrenal cells in tissue culture. Science 183, 334\u2013335.","journal-title":"Science"},{"key":"18_CR42","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/0006-291X(81)91640-5","volume":"102","author":"C. Lai","year":"1981","unstructured":"Lai, C., Cancedda, F., Duffy, L. K. (1981) ADP-ribosyl transferase activity of cholera toxin polypeptide A1, and the effect of limited trypsinolysis. Biochem Biophys Res Commun 102, 1021\u20131027.","journal-title":"Biochem Biophys Res Commun"},{"key":"18_CR43","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/1831533a0","volume":"183","author":"S. N. De","year":"1959","unstructured":"De, S. N. (1959) Enterotoxicity of Bacteria-free Culture-filtrate of Vibrio cholerae. Nature 183, 1533\u20131534.","journal-title":"Nature"},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1517\/14712598.5.7.953","volume":"5","author":"M. Vajdy","year":"2005","unstructured":"Vajdy, M., Singh, M. (2005) The role of adjuvants in the development of mucosal vaccines. Expert Opin Biol Ther 5, 953\u2013965.","journal-title":"Expert Opin Biol Ther"},{"key":"18_CR45","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/eji.200535184","volume":"35","author":"M. J. Estcourt","year":"2005","unstructured":"Estcourt, M. J., Letourneau, S., McMichael, A. J., Hanke, T. (2005) Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses. Eur J Immunol 35, 2532\u20132540.","journal-title":"Eur J Immunol"},{"key":"18_CR46","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1086\/322968","volume":"33","author":"K. Leder","year":"2001","unstructured":"Leder, K., Weller, P. F., Wilson, M. E. (2001) Travel vaccines and elderly persons: review of vaccines available in the United States. Clin Infect Dis 33, 1553\u20131566.","journal-title":"Clin Infect Dis"},{"key":"18_CR47","first-page":"192","volume":"2","author":"T. Shohat","year":"2000","unstructured":"Shohat, T., Green, M. S., Nakar, O., Ballin, A., Duvdevani, P., Cohen, A., Shohat, M. (2000) Gender differences in the reactogenicity of measles- mumps-rubella vaccine. Isr Med Assoc J 2, 192\u2013195.","journal-title":"Isr Med Assoc J"},{"key":"18_CR48","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1079\/BJN20051469","volume":"94","author":"R. Albers","year":"2005","unstructured":"Albers, R., Antoine, J. M., Bourdet-Sicard, R., Calder, P. C., Gleeson, M., Lesourd, B., Samart\u00edn, S., Sanderson, I. R., Van Loo, J., Vas Dias, F. W., Watzl, B. (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452\u2013481.","journal-title":"Br J Nutr"},{"key":"18_CR49","first-page":"329","volume":"17","author":"R. W. Kaminski","year":"1999","unstructured":"Kaminski, R. W., VanCott, T. C. (1999) Collection and processing of mucosal secretions from mice. Methods Mol Med 17, 329\u2013339.","journal-title":"Methods Mol Med"},{"key":"18_CR50","first-page":"283","volume":"17","author":"F. W. Ginkel van","year":"1999","unstructured":"van Ginkel, F. W., VanCott, J. L., Kaminski, R., VanCott, T. C. (1999) Measurement of HIV-1 specific and total antibody secreting cells by ELISPOT. Methods Mol Med 17, 283\u2013292.","journal-title":"Methods Mol Med"},{"key":"18_CR51","unstructured":"Finney, D. F. (1978) Parallel line assays. Statistical Methods in Biological Assays, 3rd edn., pp 69\u2013104."},{"key":"18_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymeth.2006.05.018","volume":"40","author":"M. Kalkanidis","year":"2006","unstructured":"Kalkanidis, M., Pietersz, G. A., Xiang, S. D., Mottram, P. L., Crimeen-Irwin, B., Ardipradja, K., Plebanski, M. (2006) Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity. Methods 40, 20\u201329.","journal-title":"Methods"},{"key":"18_CR53","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ymeth.2005.11.006","volume":"38","author":"J. H. Cox","year":"2006","unstructured":"Cox, J. H., Ferrari, G., Janetzki, S. (2006) Measurement of cytokine release at the single cell level using the ELISPOT assay. Methods 38, 274\u2013282.","journal-title":"Methods"},{"key":"18_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1046-2023(03)00124-5","volume":"31","author":"A. Letsch","year":"2003","unstructured":"Letsch, A., Scheibenbogen, C. (2003) Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining. Methods 31, 143\u2013149.","journal-title":"Methods"},{"key":"18_CR55","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1046-2023(02)00348-1","volume":"29","author":"D. D. Anthony","year":"2003","unstructured":"Anthony, D. D., Lehmann, P. V. (2003) T-cell epitope mapping using the ELISPOT approach. Methods 29, 260\u2013269.","journal-title":"Methods"},{"key":"18_CR56","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1128\/IAI.65.12.4996-5002.1997","volume":"65","author":"P. Ghiara","year":"1997","unstructured":"Ghiara, P., Rossi, M., Marchetti, M., Di Tommaso, A., Vindigni, C., Ciampolini, F., Covacci, A., Telford, J. L., De Magistris, M. T., Pizza, M., Rappuoli, R., Del Giudice, G. (1997) Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun 65, 4996\u20135002.","journal-title":"Infect Immun"}],"container-title":["Methods in Molecular Biology","Vaccine Adjuvants"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60761-585-9_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T14:47:48Z","timestamp":1685371668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-60761-585-9_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"ISBN":["9781607615842","9781607615859"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/978-1-60761-585-9_18","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-60761-585-9","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}